With the aid of spatial transcriptomics and proteomics data, we confirmed that ISG15 is highly expressed and predominantly co-located with the myCAF subcluster in breast cancer, underlining its significant role in pro-tumor. This evidence concerns the gene ISG15 and neoplasm.